Application Sponsors
ANDA 203480 | GLENMARK PHARMS LTD | |
Marketing Status
Application Products
001 | TABLET;ORAL | 625MG | 0 | COLESEVELAM HYDROCHLORIDE | COLESEVELAM HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2018-05-18 | |
LABELING; Labeling | SUPPL | 2 | AP | 2022-01-28 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2022-01-28 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2022-01-28 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2022-01-28 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 7 |
SUPPL | 3 | Null | 7 |
SUPPL | 4 | Null | 15 |
SUPPL | 5 | Null | 15 |
TE Codes
CDER Filings
GLENMARK PHARMS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 203480
[companyName] => GLENMARK PHARMS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"COLESEVELAM HYDROCHLORIDE","activeIngredients":"COLESEVELAM HYDROCHLORIDE","strength":"625MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"05\/18\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-05-18
)
)